Evaluation of chemotherapy response using technetium-99m-sestamibi scintigraphy in untreated adult malignant lymphomas and comparison with other prognosis factors: A preliminary report

International Journal of Cancer

Volumn 95, Issue 4, 2001, Pages 228-231

  Kao, Chia Hung ^a   Tsai, Shih Chuan ^b   Wang, Jhi Joung ^c   Ho, Yung Jen ^d   Ho, Shung Tai ^e   Changlai, Sheng Ping ^f  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d JEN AI HOSPITAL   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Chemotherapy response; Malignant lymphoma; Technetium 99m methoxyisobutylisonitrile

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LYMPHOMA; MALE; PRIORITY JOURNAL; PROGNOSIS; RADIOLOGICAL PARAMETERS; RISK FACTOR; SCINTIGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LYMPHOMA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC; TECHNETIUM TC 99M SESTAMIBI;

EID: 0035919887     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010720)95:4<228::AID-IJC1039>3.0.CO;2-D     Document Type: Article

References (17)

1. Principles of chemotherapy for lymphomas
2. Lymphoma
3. Hematological malignancies
4. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs
5. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblast
6. Evaluation of therapy response in children with untreated malignant lymphomas using technetium-99m-sestamibi
7. Evaluation of tumour metabolism and multidrug resistance in patients with treated malignant lymphomas
8. Frequent expression of P-glycoprotein/MDR1 by nasal T-cell lymphoma cells
9. Immunohistochemical identification of P-glycoprotein in previously untreated, diffuse large cell in immunoblastic lymphomas
10. MDR1 and MRP expression in chronic B-cell lymphoproliferative disorders
11. Expression of the multidrug resistance-associated protein gene in refractory lymphoma: Quantitation by a validated polymerase chain reaction assay
12. 99mTc-sestamibi is a substrate for P-glycoprotein and the multidrug resistance-associated protein
13. Visualization of multidrug resistance in vivo
14. Expression of mediated p-glycoprotein multidrug resistance related to Tc-99m MIBI scintimamography results
15. Comparison of the kinetics of active efflux of 99mTc-MIBI in cells with P-glycoprotein-mediated and multidrug-resistance protein-associated multidrug-resistance phenotypes
16. Technetium-99m methoxyisobutylisonitrile chest imaging of small cell lung carcinoma. Relationship to patient prognosis and chemotherapy response - A preliminary report
17. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography